InspireMD NSPR 深 沪
等待开盘 08-26 09:30:00 美东时间
0.9099
+0.040
+4.60%
华盛通- 最 高0.9099
- 今 开0.85
- 成交量 3.54万股
- 最 低 0.85
- 昨 收 0.8699
- 总市值 4230.04万
- 52周最高 2.565
- 市盈率 静 --
- 换手率 0.08%
- 52周最低 0.63
- 委 比 96.09%
- 总股本 4648.91万
- 历史最高 27890625.00
- 量 比 0.51
- 振 幅 6.89%
- 历史最低 0.63
- 每 手 1
- 风险率 0.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多InspireMD shares are trading lower after the company reported mixed Q2 financial results.
InspireMD shares are trading lower after the company reported mixed Q2 financial results.
08-18 02:25
InspireMD Q2 EPS $(0.17) Beats $(0.19) Estimate, Sales $1.771M Miss $2.133M Estimate
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 34.62 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $1.771 million which...
08-17 19:01
InspireMD to Announce Second Quarter 2026 Financial Results
InspireMD, Inc. announced it will release its second quarter financial results on August 17, 2026, and host a conference call and webcast at 8:30 a.m. Eastern Time. Interested parties can register via an online form to receive dial-in details. A live audio webcast and recording archive will be available on the company’s Investor Relations page. InspireMD specializes in carotid stent systems using its proprietary MicroNet™ mesh technology.
08-10 20:01
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD's Compensation Committee has approved inducement grants of 221,666 restricted shares to a new non-executive employee, outside the 2021 Equity Incentive Plan, under the 2024 Inducement Plan. The shares will vest over time, with portions vesting in two or three installments between 2027 and 2029, contingent on continued employment. The grants aim to incentivize the employee to join InspireMD, aligning with Nasdaq Listing Rule 5635(c)(4).
08-07 20:01
InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing
InspireMD appoints Kathleen Kennedy as Senior Vice President of Global Sales and Marketing. With over 30 years of experience in medical device sales, particularly in carotid intervention, Kennedy previously led U.S. sales for CGuard Prime. Her return strengthens InspireMD's commercial team ahead of the planned U.S. launch of CGuard Prime 80cm for TCAR procedures. CEO Marvin Slosman highlights her expertise and relationships in the field, while Ke...
07-30 20:01
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
<p>InspireMD, Inc. announced that its Compensation Committee approved inducement grants of 91,161 restricted stock shares to six new non-executive employees, outside its 2021 Equity Incentive Plan, under the 2024 Inducement Plan. The restricted stock vests over three years, with one-third vesting annually on the first, second, and third anniversaries of the grant date, contingent on continued employment. The grants aim to incentivize new hires in...
06-12 20:05
InspireMD Announces First Patient Enrolled In CGUARDIANS III Pivotal Study Of SwitchGuard Neuro Protection System, For Use With CGuard Prime 80 cm Stent Platform, In TCAR Procedures
InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the first patient has been enrolled in the
06-08 20:04
InspireMD Balances Fast Growth With U.S. Setback
InspireMD Inc (($NSPR)) has held its Q1 earnings call. Read on for the main hig...
05-11 08:21
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
Transcript: InspireMD Q1 2026 Earnings Conference Call
InspireMD (NASDAQ:NSPR) released first-quarter financial results and hosted an ...
05-05 05:14
